Second, the elevated serum Nrg4 levels in T2DM patients may represent a compensatory response to reduced Nrg4 expression in adipose tissue or impaired Nrg4/ErbB signaling pathway mediated by receptor resistance (Kang et al., 2016; Chen et al., 2017b). Here, NRG4 is linked to type 2 diabetes mellitus.